Trusted Resources: Education
Scientific literature and patient education texts
Mucopolysaccharidosis Type I Diagnosed by Aortic and Mitral Valve Replacement
source: JACC. Case reports
year: 2021
authors: Sherwood DJ,Adams MC,Mazzella AJ,Abid A,Prasada S,Muenzer J,Johnson SM,Yeung M
summary/abstract:A 32-year-old developmentally delayed man presenting with dyspnea was found to have severe aortic and mitral valve stenosis. After double valve replacement, unique histologic findings prompted a genetics evaluation, ultimately leading to the diagnosis of mucopolysaccharidosis type I, a rare lysosomal storage disorder with high rates of cardiac manifestations. ().
organization: Department of Medicine, University of North Carolina Hospitals, Chapel Hill, North Carolina, USA.DOI: 10.1016/j.jaccas.2021.10.013
read more
BookmarkRelated Content
-
Elizabeth F. Neufeld, PhDBorn in France, Elizabeth Neufeld immigr...
-
The Beginning of the End of Allogeneic Transplantation for Hurler SyndromeHurler syndrome (mucopolysaccharidosis t...
-
Stem Cell Transplant for Bridgnorth Boy With Rare ConditionTwenty-two-month-old Gunner, from Bridgn...
-
A Guide to Understanding MPS I (Hurler, Hurler-Scheie, and Scheie Syndromes)What Is MPS I? Mucopolysaccharidosis I (...
-
Experimental MPS 1 Therapy Shows Biomarker Activity, Improved FunctionREGENXBIO presented results from its ong...
-
Inhibition of Iduronic Acid Biosynthesis by Ebselen Reduces Glycosaminoglycan Accumulation in Mucopolysaccharidosis ...Mucopolysaccharidosis type I (MPS-I) is ...
-
Evidence of Treatment Benefits in Patients With Mucopolysaccharidosis Type I-Hurler in Long-Term Follow-Up Using a N...We developed a brain and spine magnetic ...
Powered by
